Your browser doesn't support javascript.
loading
Predictive capacity of a miRNA panel in identifying teratoma in post-chemotherapy consolidation surgeries.
Moore, Joseph A; Lehner, Michael J; Anfossi, Simone; Datar, Saumil; Tidwell, Rebecca S; Campbell, Matthew; Shah, Amishi Y; Ward, John F; Karam, Jose A; Wood, Christopher G; Pisters, Lois L; Calin, George A; Tu, Shi-Ming.
Afiliação
  • Moore JA; Department of Genitourinary Medical Oncology Division of Cancer Medicine, University of Texas MD Anderson Cancer Center Houston TX.
  • Lehner MJ; Department of Internal Medicine University of Texas Health Science Center at Houston Houston TX USA.
  • Anfossi S; Department of Translational Molecular Pathology Division of Pathology/Lab Medicine, University of Texas MD Anderson Cancer Center Houston TX.
  • Datar S; Department of Internal Medicine University of Texas Health Science Center at Houston Houston TX USA.
  • Tidwell RS; Department of Biostatistics University of Texas MD Anderson Cancer CenterTX Houston TX.
  • Campbell M; Department of Genitourinary Medical Oncology Division of Cancer Medicine, University of Texas MD Anderson Cancer Center Houston TX.
  • Shah AY; Department of Genitourinary Medical Oncology Division of Cancer Medicine, University of Texas MD Anderson Cancer Center Houston TX.
  • Ward JF; Department of Urology Division of Surgery, University of Texas MD Anderson Cancer Center Houston TX.
  • Karam JA; Department of Urology Division of Surgery, University of Texas MD Anderson Cancer Center Houston TX.
  • Wood CG; Department of Urology Division of Surgery, University of Texas MD Anderson Cancer Center Houston TX.
  • Pisters LL; Department of Urology Division of Surgery, University of Texas MD Anderson Cancer Center Houston TX.
  • Calin GA; Department of Translational Molecular Pathology Division of Pathology/Lab Medicine, University of Texas MD Anderson Cancer Center Houston TX.
  • Tu SM; Department of Genitourinary Medical Oncology Division of Cancer Medicine, University of Texas MD Anderson Cancer Center Houston TX.
BJUI Compass ; 4(1): 81-87, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36569509

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: BJUI Compass Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: BJUI Compass Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos